Wei Li

High Impact

Assistant Professor

University of Arkansas for Medical Sciences

faculty

CHP | Dietetic Internship

27 h-index 231 pubs 3,096 cited

Research Areas

Dermatology and Skin Diseases Immune Response and Inflammation Cancer Treatment and Pharmacology Gut microbiota and health Molecular Biology Techniques and Applications Health and Medical Research Impacts Meta-analysis and systematic reviews

Links

ORCID UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Wei Li's research program focuses on investigating the molecular mechanisms underlying inflammatory skin diseases, particularly psoriasis and bullous pemphigoid. His work has explored the role of specific cytokines, such as IL-17A, and their targeted antibodies in cancer treatment, as well as their involvement in conditions like psoriasis.

Recent publications by Li and his collaborators include an evaluation of Dupilumab in patients with bullous pemphigoid, an examination of Janus kinase inhibitors like Baricitinib for treating concurrent bullous pemphigoid and plaque psoriasis, and research into the applications of single-cell RNA sequencing in atopic dermatitis and psoriasis. Further studies have investigated the gut microbiota marker *Eubacterium rectale* in psoriasis and psoriatic arthritis, and the contribution of SerpinB7 deficiency to psoriasis development through calcium-mediated keratinocyte differentiation dysfunction.

Li's scholarly contributions are evidenced by a high-impact researcher designation, an h-index of 27, over 230 publications, and more than 3,000 citations. His recent activity and publication record indicate ongoing engagement in health sciences research.

Metrics

h-index: 27
Publications: 231
Citations: 3,096

Selected Publications

Autoimmune bullous diseases: pathogenesis and clinical management (2025) DOI
BMI matters: understanding the link between weight and severe psoriasis (2025) DOI
Genome sequence of the broad-host-range phage phi1_092033 against <i>Acinetobacter baumannii</i> (2025) DOI
Effects of Inclisiran, Alirocumab, Evolocumab, and Evinacumab on Lipids: A Network Meta-Analysis (2025) DOI
Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists (2025) DOI
Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis (2025) DOI
Comparative study of high-power single-frequency fiber amplifiers at 1.5 μm based on absorption control of Er/Yb co-doped active fiber (2024) DOI
Theoretical and experimental study on optical polarization states in overhead optical cables under complex weather conditions such as real lightning (2024) DOI
Pyroptosis in asthma: inflammatory phenotypes, immune and non-immune cells, and novel treatment approaches (2024) DOI
Cambricon-D: Full-Network Differential Acceleration for Diffusion Models (2024) DOI
Successful treatment of Giant keloid on the right toes using trepanation combined with superficial radiotherapy (SRT-100): a case report with literature review (2024) DOI
Treatment with immunosuppressants did not increase the risk of COVID-19 in pemphigus patients: A single-center survey-based study (2024) DOI
Single-Cell Transcriptome Analysis Reveals Interaction between CCL19+ Inflammatory Keratinocytes and CCR7+ Dendritic Cells and B Cells in Pemphigus (2024) DOI
<i>Eubacterium rectale</i>is a potential marker of altered gut microbiota in psoriasis and psoriatic arthritis (2024) DOI
Ofatumumab subcutaneous injection successfully treated patients with pemphigus vulgaris relapse post rituximab (2024) DOI